- Home
- TWIN vs CRDL Comparison
TWIN vs CRDL Comparison
Compare TWIN & CRDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWIN
- CRDL
- Stock Information
- Founded
- TWIN 1918
- CRDL 2017
- Country
- TWIN United States
- CRDL Canada
- Employees
- TWIN N/A
- CRDL N/A
- Industry
- TWIN Industrial Machinery/Components
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TWIN Industrials
- CRDL Health Care
- Exchange
- TWIN Nasdaq
- CRDL Nasdaq
- Market Cap
- TWIN 123.7M
- CRDL 102.0M
- IPO Year
- TWIN N/A
- CRDL N/A
- Fundamental
- Price
- TWIN $7.68
- CRDL $0.96
- Analyst Decision
- TWIN
- CRDL Strong Buy
- Analyst Count
- TWIN 0
- CRDL 3
- Target Price
- TWIN N/A
- CRDL $9.00
- AVG Volume (30 Days)
- TWIN 42.1K
- CRDL 241.3K
- Earning Date
- TWIN 04-29-2025
- CRDL 05-13-2025
- Dividend Yield
- TWIN 2.10%
- CRDL N/A
- EPS Growth
- TWIN N/A
- CRDL N/A
- EPS
- TWIN 0.68
- CRDL N/A
- Revenue
- TWIN $321,398,000.00
- CRDL N/A
- Revenue This Year
- TWIN N/A
- CRDL N/A
- Revenue Next Year
- TWIN N/A
- CRDL N/A
- P/E Ratio
- TWIN $11.77
- CRDL N/A
- Revenue Growth
- TWIN 9.23
- CRDL N/A
- 52 Week Low
- TWIN $7.35
- CRDL $0.88
- 52 Week High
- TWIN $18.00
- CRDL $3.12
- Technical
- Relative Strength Index (RSI)
- TWIN 35.25
- CRDL 34.30
- Support Level
- TWIN $8.00
- CRDL $1.10
- Resistance Level
- TWIN $8.84
- CRDL $1.18
- Average True Range (ATR)
- TWIN 0.41
- CRDL 0.09
- MACD
- TWIN 0.09
- CRDL -0.01
- Stochastic Oscillator
- TWIN 28.19
- CRDL 22.95
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.